PharmaEssentia Corp (藥華醫藥) on Monday said that Besremi (Ropeginterferon alfa-2b), its treatment for people with polycythemia vera, a rare form of blood cancer, has gained marketing approval from Taiwan's Food and Drug Administration (FDA).
It was the drug’s second regulatory approval, following approval from the European Medicines Agency in February last year.
PharmaEssentia would soon begin to mass produce the drug, it said in a statement, adding that it would apply to the National Health Insurance Administration to have the drug included in the National Health Insurance (NHI) system.
There are about 3,000 people with polycythemia vera in Taiwan and the company plans to offer the drug to those who can pay for it out of pocket until it is accepted into the NHI system, it said.
Each dose of Besremi sold for about 3,000 euros (US$3,362) in Europe last year, the company said, adding that the local price has yet to be decided.
The company submitted the application for Besremi to Taiwan's FDA on July 31 last year, saying that it took the regulator a relatively shorter review period to give it the green light.
PharmaEssentia said that after submitting an application in March, it expects the drug to gain approval from the US Food and Drug Administration at the beginning of next year.
The US regulator on May 22 gave approval for PharmaEssentia to test Besremi for use against COVID-19 under the Coronavirus Treatment Acceleration Program.
The interferon drug modulates immune response by interfering with viral proliferation.
The firm plans to recruit 40 volunteers to test if the drug can reduce the possibility of a COVID-19 infection, it said.
Taiwanese suppliers to Taiwan Semiconductor Manufacturing Co. (TSMC, 台積電) are expected to follow the contract chipmaker’s step to invest in the US, but their relocation may be seven to eight years away, Minister of Economic Affairs J.W. Kuo (郭智輝) said yesterday. When asked by opposition Chinese Nationalist Party (KMT) Legislator Niu Hsu-ting (牛煦庭) in the legislature about growing concerns that TSMC’s huge investments in the US will prompt its suppliers to follow suit, Kuo said based on the chipmaker’s current limited production volume, it is unlikely to lead its supply chain to go there for now. “Unless TSMC completes its planned six
Intel Corp has named Tasha Chuang (莊蓓瑜) to lead Intel Taiwan in a bid to reinforce relations between the company and its Taiwanese partners. The appointment of Chuang as general manager for Intel Taiwan takes effect on Thursday, the firm said in a statement yesterday. Chuang is to lead her team in Taiwan to pursue product development and sales growth in an effort to reinforce the company’s ties with its partners and clients, Intel said. Chuang was previously in charge of managing Intel’s ties with leading Taiwanese PC brand Asustek Computer Inc (華碩), which included helping Asustek strengthen its global businesses, the company
Power supply and electronic components maker Delta Electronics Inc (台達電) yesterday said second-quarter revenue is expected to surpass the first quarter, which rose 30 percent year-on-year to NT$118.92 billion (US$3.71 billion). Revenue this quarter is likely to grow, as US clients have front-loaded orders ahead of US President Donald Trump’s planned tariffs on Taiwanese goods, Delta chairman Ping Cheng (鄭平) said at an earnings conference in Taipei, referring to the 90-day pause in tariff implementation Trump announced on April 9. While situations in the third and fourth quarters remain unclear, “We will not halt our long-term deployments and do not plan to
TikTok abounds with viral videos accusing prestigious brands of secretly manufacturing luxury goods in China so they can be sold at cut prices. However, while these “revelations” are spurious, behind them lurks a well-oiled machine for selling counterfeit goods that is making the most of the confusion surrounding trade tariffs. Chinese content creators who portray themselves as workers or subcontractors in the luxury goods business claim that Beijing has lifted confidentiality clauses on local subcontractors as a way to respond to the huge hike in customs duties imposed on China by US President Donald Trump. They say this Chinese decision, of which Agence
RSS